310 Clinical Research
Inglewood, California 90301
7 studies enrolling now · 17 studies all time
What they study most
Atherosclerotic Cardiovascular Disease (ASCVD), Atopic Dermatitis, COVID-19, COVID-19 SARS-CoV-2 Infection, Cardiovascular Disease, Chronic Idiopathic Constipation (CIC), Chronic Spontaneous Urticaria, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Elevated Lp(a), Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction
Studies at this site
- OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events — Recruiting now
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease — Recruiting now
- A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
- LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis — Recruiting now
- LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis — Recruiting now
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity — Recruiting now
- A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults — Recruiting now
- Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes — Running, not enrolling
- A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER) — Completed
- A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1) — Running, not enrolling
- A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
- Efficacy and Safety of NVX-CoV2705 — Running, not enrolling
- A Study of Barzolvolimab in Patients With Atopic Dermatitis — Running, not enrolling
- Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria — Running, not enrolling
- A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes — Completed
- Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions — Completed